Researchers have launched a clinical trial to develop a breath test, analysing molecules that could indicate the presence of cancer at an early stage.
Jan 3, 2019
0
1
The discovery of three biomarkers that detect mild cognitive impairment and Alzheimer's has the potential to lead to the development of a saliva test to diagnose the chronic neurodegenerative disease.
Dec 6, 2018
0
4
(HealthDay)—A majority of internists still report financial ties to industry, according to a study published online Oct. 5 in the Journal of General Internal Medicine.
Nov 6, 2018
0
0
(HealthDay)—Sofosbuvir-based treatment appears to guarantee renal safety for patients with chronic hepatitis C virus over one year of follow-up, according to a study published online May 7 in the Journal of Clinical Pharmacy ...
May 11, 2018
0
2
Microscopes enhanced with artificial intelligence (AI) could help clinical microbiologists diagnose potentially deadly blood infections and improve patients' odds of survival, according to microbiologists at Beth Israel Deaconess ...
Dec 15, 2017
0
10
In a first-of-its-kind study, University of California San Diego School of Medicine researchers report that a blood sample, or liquid biopsy, can reveal which patients will respond to checkpoint inhibitor-based immunotherapies.
Oct 2, 2017
0
3
People with low levels of vitamin A living with individuals sick with tuberculosis may be 10 times more likely to develop the disease than people with high levels of the nutrient, according to research led by investigators ...
Jun 12, 2017
0
0
A study in Neurology suggests that analyzing levels of the protein p75ECD in urine samples from people with amyotrophic lateral sclerosis (ALS) may help monitor disease progression as well as determine the effectiveness of ...
Mar 22, 2017
0
1
(HealthDay)—Mass spectrometry (MS)-based profiling combined with clinical variables can identify nonalcoholic steatohepatitis (NASH), according to a study published in the October issue of Clinical Gastroenterology and ...
Oct 6, 2016
0
0
Among patients with stage IV melanoma who were being treated with the immunotherapeutic pembrolizumab (Keytruda), the ratio of a particular subset of immune cells in the blood to tumor burden correlated with clinical response, ...
Sep 27, 2016
0
0
